Martin Shkreli resigns as CEO of Turing Pharmaceuticals after being charged with securities fraud
‘Turing Pharmaceuticals CEO Martin Shkreli, who was charged Thursday with securities fraud, has resigned his position.
The company said board chairman Ron Tilles has been named interim CEO.
Shkreli was arrested in New York City and charged with securities fraud related to his former hedge fund and a drug company he once ran.’
The post Martin Shkreli resigns as CEO of Turing Pharmaceuticals after being charged with securities fraud appeared first on David Icke.
Leave a Reply